What You Really Need to Know About Semaglutide, Tirzepatide, and Medical Weight Loss At Peak Medical, we are focused on debunking common myths about weight loss medications because we know that weight loss is deeply personal and more than just a number on the scale—it’s about reclaiming your energy, confidence, and overall [...]
Weight significantly impacts cardiovascular risk, especially excess abdominal fat, which raises the chances of high blood pressure, high cholesterol, and insulin resistance—major contributors to heart disease. Fortunately, advanced weight loss treatments now not only help shed pounds but also enhance metabolic and heart health. Among the most promising advances are GLP-1 receptor agonists [...]
At Peak Medical, we believe health and vitality matter at every age. Semaglutide and Tirzepatide, originally developed for type 2 diabetes, are now recognized for broader benefits beyond blood sugar control. These GLP-1 receptor agonists support weight loss, heart health, and cognitive function, helping adults of all ages improve longevity and well-being. [...]
As we age, maintaining health and vitality becomes increasingly important. One area gaining attention is the use of GLP-1 (glucagon-like peptide-1) receptor agonists. Initially developed for managing type 2 diabetes, these medications are now recognized for their broader benefits, particularly in promoting healthy aging and longevity. Despite their potential, these medications remain underutilized [...]
Semaglutide and Tirzepatide have gained significant attention in the medical community primarily for their effectiveness in managing type 2 diabetes and facilitating weight loss. However, these medications, classified as GLP-1 receptor agonists (for Semaglutide) and dual GLP-1/GIP receptor agonists (for Tirzepatide), are now being explored for a variety of other potential health benefits beyond [...]
Semaglutide Program from Peak Medical It's being touted as a game-changer in the world of weight loss drugs because, well, it actually works. A large study was published recently in the New England Journal of Medicine showing some pretty impressive weight loss effects in non-diabetics taking semaglutide. 50% of people [...]
